Literature DB >> 2684615

Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations.

S J Koopmans1, H C Sips, J Bosman, J K Radder, H M Krans.   

Abstract

Insulin action on adipocytes induces two major metabolic effects: stimulation of glucose transport and inhibition of lipolysis. Previously, we have shown that incubated isolated adipocytes from starved (S), and streptozotocin-treated diabetic (D) rats show insulin resistance on glucose transport. It is not known whether insulin resistance is also present on antilipolysis. In this study the antilipolytic action of insulin was investigated. Since basal lipolysis was low, lipolysis was first stimulated by isoproterenol (ISO). This showed that differences existed in sensitivity for ISO among control (C), S, and D adipocytes. We investigated whether changes in adenosine accumulation could attribute to the differences in ISO action and thereby influence insulin action. When endogenous accumulating adenosine was removed by adenosine deaminase and replaced by a fixed concentration (200 nM) of the nonhydrolyzable adenosine analog phenylisopropyladenosine, the differences in ISO action disappeared. This indicates that the sensitivity of C, S, and D adipocytes for ISO is strongly influenced by endogenous adenosine release. The dose-response relationship between insulin and inhibition of ISO-stimulated lipolysis showed that insulin sensitivity was increased and responsiveness unaltered in S and D compared to C adipocytes for incubations with both uncontrolled and controlled adenosine concentrations. This indicates that during S and D states, endogenous adenosine release has no major effect on insulin action. The increased sensitivity for insulin of S and D adipocytes was paralleled by an increased binding of [125I]iodoinsulin. The unaltered responsiveness for insulin indicates that there is no insulin resistance at the postbinding level for antilipolysis, i.e. intracellular processes for antilipolysis are intact. This is in contrast to glucose transport, where insulin resistance exists at the postbinding level during S and D. Thus, insulin resistance is no general phenomenon, but is confined to specific effector systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684615     DOI: 10.1210/endo-125-6-3044

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis.

Authors:  S J Koopmans; H C Sips; H M Krans; J K Radder
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

2.  Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.

Authors:  S J Koopmans; A D van Mansfeld; H S Jansz; H M Krans; J K Radder; M Frölich; S F de Boer; D K Kreutter; G C Andrews; J A Maassen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

3.  Comparative effects of 6 week fructose, dextrose and starch feeding on fat-cell lipolysis in normal rats: effects of isoproterenol, theophylline and insulin.

Authors:  S W Rizkalla; J Luo; I Guilhem; J Boillot; F Bruzzo; A Chevalier; G Slama
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

4.  Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity.

Authors:  Jae-Geun Lee; Dong Gu Kang; Jung Re Yu; Youngree Kim; Jinsoek Kim; Gwanpyo Koh; Daeho Lee
Journal:  Diabetes Metab J       Date:  2011-04-30       Impact factor: 5.376

5.  Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.

Authors:  Nagesh Gowda; Anilkumar Dandu; Jaideep Singh; Sanghamitra Biswas; Vijaya Raghav; Mudigere N Lakshmi; Pavagada C Shilpa; Venkategowda Sunil; Ashokkumar Reddy; Manojkumar Sadasivuni; Kumaraswamy Aparna; Mahesh Kumar Verma; Yoganand Moolemath; Mammen O Anup; Marikunte V Venkataranganna; Baggavalli P Somesh; Madanahalli R Jagannath
Journal:  BMC Pharmacol Toxicol       Date:  2013-05-21       Impact factor: 2.483

6.  The relationship between adenosine deaminase and heart rate-corrected QT interval in type 2 diabetic patients.

Authors:  Chun-Feng Lu; Xiao-Qin Ge; Yan Wang; Jian-Bin Su; Xue-Qin Wang; Dong-Mei Zhang; Feng Xu; Wang-Shu Liu; Min Su
Journal:  Endocr Connect       Date:  2021-08-03       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.